SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,149,000 | -21.2% | 1,824,542 | 0.0% | 17.55% | +4.1% |
| Q3 2021 | $34,466,000 | +1.6% | 1,824,542 | 0.0% | 16.86% | +14.1% |
| Q2 2021 | $33,918,000 | -18.3% | 1,824,542 | 0.0% | 14.78% | -5.0% |
| Q1 2021 | $41,527,000 | +4.8% | 1,824,542 | 0.0% | 15.56% | -18.5% |
| Q4 2020 | $39,611,000 | +116.0% | 1,824,542 | 0.0% | 19.08% | +105.4% |
| Q3 2020 | $18,337,000 | +29.5% | 1,824,542 | 0.0% | 9.29% | -5.4% |
| Q2 2020 | $14,158,000 | -23.9% | 1,824,542 | 0.0% | 9.82% | -37.1% |
| Q1 2020 | $18,610,000 | -7.3% | 1,824,542 | 0.0% | 15.61% | +28.4% |
| Q4 2019 | $20,070,000 | +21.0% | 1,824,542 | 0.0% | 12.16% | +4.4% |
| Q3 2019 | $16,584,000 | -20.1% | 1,824,542 | 0.0% | 11.65% | -16.4% |
| Q2 2019 | $20,763,000 | -0.1% | 1,824,542 | 0.0% | 13.94% | +14.3% |
| Q1 2019 | $20,781,000 | +26.3% | 1,824,542 | 0.0% | 12.19% | +20.3% |
| Q4 2018 | $16,457,000 | -39.9% | 1,824,542 | 0.0% | 10.13% | +26.4% |
| Q3 2018 | $27,368,000 | – | 1,824,542 | – | 8.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |